GeneNews Receives $608K Grant to Commercialize ColonSentry in Malaysia | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews today announced the approval of almost MYR1.9 million ($608,000) in a seed capital grant from the Malaysian Biotechnology Corporation to support the commercial launch of the ColonSentry colorectal cancer diagnostic test in Malaysia.

The test will be made available in Malaysia through GeneNews Diagnostics, a privately held Malaysian firm that will also work with GeneNews to introduce ColonSentry in the rest of Southeast Asia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.